Tier 1 — highest

Collagen supplementation for skin health: a mechanistic systematic review

Meisam Barati, Masoumeh Jabbari, Roya Navekar, Fariba Farahmand, Reihaneh Zeinalian, Ammar Salehi-Sahlabadi, Nasrin Abbaszadeh, Amin Mokari-Yamchi, Sayed Hossein Davoodi
Journal of Cosmetic Dermatology 2020 19(11):2820–2829

Bibliography

PubMed
PMID 32436266
Funding
Funding statement (verbatim): "Student Research Committee, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran, Grant/Award Number: 1397/70756"
Competing interests
Competing interests: No explicit statement of conflict of interest surfaced. All nine authors are affiliated with Iranian academic and research institutions (Shahid Beheshti University of Medical Sciences, Tabriz University of Medical Sciences, Tehran University of Medical Sciences). No commercial industry ties surfaced. Government-institution-funded via Student Research Committee grant — much cleaner commercial-independence profile than industry-funded reviews such as Bello & Oesser 2006.

Study snapshot

DesignSystematic review of clinical trials assessing effects of collagen supplementation on skin health parameters, with mechanistic focus on biological explanations for observed effects
ModelLiterature review — assessed 9,057 initial items reduced through screening to 10 included publications
SampleNot applicable — review paper. Aggregate evidence across included clinical trials.
InterventionReview methodology — trials covered used oral hydrolysed or intact collagen at doses ranging 500 mg to 10 g/day, durations 4 weeks to 12 weeks, in healthy or patient populations
DurationDatabase searches through the review methodology date; included publications spanned recent decades
EndpointsSynthesis of skin health outcomes across included trials; Identification of mechanistic pathways (direct fibroblast effects, M2-like macrophage polarisation, oral tolerance mechanisms); Assessment of consistency of findings across included studies

What the study showed, in plain terms

By 2020, dozens of clinical trials had tested oral collagen for skin health, but the vast majority had been funded by commercial collagen manufacturers. What the field needed was an independent systematic review — one that could pull together all the published evidence and ask two questions: does oral collagen actually improve skin, and if it does, what is the biological mechanism that makes it work?

A team at Shahid Beheshti University of Medical Sciences in Tehran took on this task. They searched multiple scientific databases and identified 9,057 initial items, then screened these down to 10 clinical trials that met their inclusion criteria — randomised, controlled, published in peer-reviewed journals, and specifically examining oral collagen's effects on skin health parameters. Unlike a typical systematic review that just tallies the results, this one focused on the mechanistic question: how does swallowed collagen actually change skin at the cellular level?

The findings on the clinical side are unambiguous. All of the included studies reported beneficial effects of collagen supplementation on skin health, with no inconsistencies across trials — a remarkably consistent literature. On the mechanistic side, the authors identified three distinct biological pathways through which oral collagen may act: direct effects of collagen-derived peptides on skin fibroblasts (the cells that build the dermal matrix), induction of M2-like macrophage polarisation (an anti-inflammatory shift in immune cell behaviour), and activation of oral-tolerance-related mechanisms in the gut immune system. The three-mechanism model provides biological plausibility for how a swallowed protein could produce skin-level effects that surface measurements alone cannot fully explain. This is the paper the pillar's mechanism section should lead with.

Key findings

  • Systematic search identified 9,057 initial items, reduced through screening to 10 included studies meeting inclusion criteria.
  • All included studies reported beneficial effects of collagen supplementation on skin health parameters — no methodological or reporting inconsistencies observed across the included body of evidence.
  • Three distinct mechanistic pathways proposed for oral collagen action on skin: (1) direct effects on skin fibroblasts via absorbed bioactive peptides (Pro-Hyp, Gly-Pro-Hyp), (2) induction of M2-like macrophage polarisation (anti-inflammatory shift), (3) oral-tolerance-related mechanisms in gut-associated immune tissue.
  • Concludes that both intact and hydrolysed collagen improve clinical manifestations of skin health.
  • Government-institution-funded systematic review with academic authorship — free of industry conflicts of interest that characterise the individual RCTs included in the review.
  • Complements Pu 2023 (which focused on effect-size synthesis) by providing the mechanistic hypothesis framework the field needed.

What this study can and cannot tell us

  • Only 10 studies included after screening — small evidence base for a systematic review. Additional relevant trials published after the search date are not incorporated.
  • Search criteria and specific database sources not fully detailed in the extracted PDF sections — verify PRISMA compliance from full text.
  • Inclusion of both intact and hydrolysed collagen may obscure differences between these two supplementation approaches.
  • Mechanistic pathways proposed are supported by cell culture and animal evidence, not directly demonstrated in the reviewed clinical trials — the mechanism model is inferential.
  • All 10 included studies reporting positive findings raises publication-bias concerns — the systematic search may not have captured null or negative trials that were less likely to be indexed.
  • No quantitative meta-analysis of effect sizes — a mechanistic-focused review provides different information than a magnitude-focused meta-analysis such as Pu 2023.
  • Explicit competing interests statement not surfaced in the extracted PDF text — verify from full manuscript.
Reviewed by , Medical Advisory Board · Last verified against PubMed on 30 August 2026